Effect of Tarragon on type 2 diabetes

Phase 3

• Conditions: Diabetes.; Type 2 diabetes mellitus

• Registration Number: IRCT20170822035834N3
• Lead Sponsor: Mazandaran University of Medical Scienses

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Moderate physical activity
Fasting blood glucose between 140 to 200
cooperation tendency

Exclusion Criteria

Insulin use
HbA1c more than 9% or less than 6%
Pregnancy and breast feeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood sugar: type 2 diabetic people with FBS in range of 140-200 mg/dl. Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;HbA1c: type 2 diabetic people with HbA1c 7-9%. Timepoint: beginning and end of study. Method of measurement: ELISA kit.;Insulin: rate of insulin secretion in patients. Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;High Density Lipoprotein (HDL). Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;Low Density Lipoprotein (LDL). Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;Very Low Density Lipoprotein (VLDL). Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;. Timepoint: . Method of measurement: .;Blood Cholestrol. Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.;Blood Triglyceride. Timepoint: At the beginning and the end of study. Method of measurement: ELISA kit.